Mecamylamine/Nicotine

美加明/尼古丁

Report date: 2022/01/24 09:14:47

Base Information

Drug NameMecamylamine/Nicotine

Drug Alias Name尼古丁美加明Nicotine/MecamylamineMecamylamine and Nicotine尼古丁/美加明Nicotine and Mecamylamine +[6]

ClassificationSmall molecules

Mechanisms of ActionAcetylcholine receptor; alpha1/beta1/delta/gamma antagonistsMuscle-type nicotinic acetylcholine receptor agonistsAcetylcholine receptor; alpha1/beta1/delta/gamma agonists

TargetsAcetylcholine receptor; alpha1/beta1/delta/gammaMuscle-type nicotinic acetylcholine receptor

Therapy Area/IndicationsTobacco Use Disorder

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsYes Mecamylamine Hydrochloride Nicotine

Global Highest StatusDiscontinued (Phase 3 Clinical)

Highest Status in ChinaN/A

Originator CompaniesElan Pharma International Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesElan Corp

Active IndicationsN/A

Inactive IndicationsTobacco Use Disorder

Other Information

ATC CodeN/A